EDU 29 - Emerging Diagnostic and Therapeutic Options for Meningioma

Moderator(s)

• 

  Sabin Motwani, MD

  Jersey City Medical Center Radiation Oncology
  Jersey City, NJ

In the past five years, the ASTRO Annual Meeting has not had a formal education session on the management of meningioma, the most common intracranial tumor. Over the last several years there has been newer data on the use of novel PET imaging, molecular stratification and clinical trials in the space of WHO Grade II and Grade III meningiomas, along with clinical considerations of when to administer radiosurgery versus fractionated radiotherapy and technical considerations of incorporating novel techniques of radiosurgery, proton therapy and radiopharmaceutical therapy. The session hopes to highlight these emerging trends with a diverse panel of multidisciplinary speakers.

Presentations:

• 3:00 PM – 3:02 PM ET

  Introduction of Speakers
  

  Speaker: Sabin Motwani, MD – Jersey City Medical Center Radiation Oncology
• 3:02 PM – 3:14 PM ET

  Molecular Stratification of Meningiomas
  

  Speaker: David Raleigh, MD, PhD – University of California, San Francisco
• 3:14 PM – 3:26 PM ET

  DOTATATE PET Imaging of Meningiomas
  

  Speaker: Jana Ivanidze, MD, PhD – NewYork-Presbyterian/Weill Cornell Medical Center
• 3:26 PM – 3:38 PM ET

  Neurosurgical Approach to Meningiomas and Incorporation of Molecular Stratification
  

  Speaker: Gelareh Zadeh, MD, PhD – University Health Network
• 3:38 PM – 3:50 PM ET

  Radiation for High-Risk Meningiomas & Radiotherapeutic Approaches to Meningioma and Discussion of NRG trials, Past, Present and Future
  

  Speaker: Joshua Palmer, MD – The James Cancer Hospital & Solove Research Institute
• 3:50 PM – 4:00 PM ET

  Questions and Answers
  

  Speaker: Sabin Motwani, MD – Jersey City Medical Center Radiation Oncology